CELEX: 32006M4064
Language: en
Date: 2006-02-10 00:00:00
Title: Commission Decision of 10/02/2006 declaring a concentration to be compatible with the common market (Case No COMP/M.4064 - MONTAGU / BSN MEDICAL) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

|

32006M4064

Commission Decision of 10/02/2006 declaring a concentration to be compatible with the common market (Case No COMP/M.4064 - MONTAGU / BSN MEDICAL) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)  

          |COMMISSION OF THE EUROPEAN COMMUNITIES     |
            Brussels , 10/02/2006
             SG-Greffe(2006) D/200646
             MERGER PROCEDURE ARTICLE 6(1)(b) DECISION
             SIMPLIFIED PROCEDURE
             PUBLIC VERSION
              
              To the notifying party
             Dear Madam(s) and/or Sir(s),
             Subject: Case No. COMP/M. 4064 – Montagu / BSN Medical Notification of 09.01.2006 pursuant to Article 4 of Council Regulation (EC) No. 139/2004  [1]  Publication in the Official Journal of the European Union No. C 011 of 17.01.2006, page 2
            1.  On 09.01.2006, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No. 139/2004 by which the undertaking Montagu Private Equity Ltd (“MPE”, UK), through several managed funds, acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking BSN Medical GmbH & Co. KG (“BSN”, Germany) by way of purchase of shares.
            2.  The business activities of the undertakings concerned are:
              - for MPE: management of private equity funds;
              - for BSN: production of professional medical products.
            3.  After examination of the notification, the Commission has concluded that the notified operation falls within the scope of Council Regulation (EC) No. 139/2004 and of paragraph 5, subparagraph b, of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No. 139/2004 [2]  .  
            4.  For the reasons set out in the Notice on a simplified procedure, the Commission has decided not to oppose the notified operation and to declare it compatible with the common market and with the EEA Agreement.  This decision is adopted in application of Article 6(1)(b) of Council Regulation (EC) No. 139/2004.
             For the Commission
             (signed)   Neelie KROES Member of the Commission
            [1] OJ L 24, 29.1.2004 p. 1
            [2] OJ C 56, 05.3.2005 p.32